GEMS (General Electric Medical Systems) deal adds genomics to imaging
This article was originally published in Clinica
Executive Summary
General Electric Medical Systems (GEMS) is combining its imaging skills in an alliance with genomics and proteomics company Genometrix. The companies claim that genetic and protein data added to diagnostic imaging will enhance early diagnosis of cancer and other diseases.